Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1Tesla

Neuro-Oncology

Volumn 14, Issue 8, 2012, Pages 1050-1061

  Chaumeil, Myriam M ^a   Gini, Beatrice ^b   Yang, Huijun ^b   Iwanami, Akio ^b   Sukumar, Subramaniam ^a   Ozawa, Tomoko ^c   Pieper, Russel O ^c   Mischel, Paul S ^b   James, C David ^c   Berger, Mitchel S ^c   Ronen, Sabrina M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

glioblastoma; MPIO; stem cell tracking; tropism

Indexed keywords

CONTRAST MEDIUM; IRON OXIDE; IRON OXIDE MICROPARTICLE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; GLIOBLASTOMA; HISTOLOGY; HUMAN; HUMAN CELL; IMAGE QUALITY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NEURAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; STEM CELL TRANSPLANTATION; TROPISM; TUMOR LOCALIZATION;

ANIMALS; BRAIN NEOPLASMS; CELL MOVEMENT; FEMALE; FERRIC COMPOUNDS; FETAL STEM CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; NEOPLASMS, EXPERIMENTAL; NEURAL STEM CELLS; NEUROIMAGING; STEM CELL TRANSPLANTATION;

EID: 84864665662     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos126     Document Type: Article

References (41)

1. CBRTUS. Statistical report - Primary brain and central nervous system tumors diagnosed in the United states in 2004-2006. 2010. http:// seer.cancer.gov/.
2. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109.
3. Clarke J, Butowski N, Chang S. Recent advances in therapy for glioblastoma. Arch Neurol. 2010;67(3):279-283.
4. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466.
5. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
6. Belda-Iniesta C, de Castro Carpeno J, Sereno M, Gonzalez-Baron M, Perona R. Epidermal growth factor receptor and glioblastoma multiforme: molecular basis for a newapproach. Clin TranslOncol. 2008;10(2):73-77.
7. Stupp R, Tonn JC, Brada M, Pentheroudakis G. High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl 5):v190-v193.
8. James CD, Cavenee WK. Stem cells for treating glioblastoma: how close to reality? Neuro Oncol. 2009;11(2):101.
9. Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA. 2000;97(23):12846-12851.
10. Tang Y, Shah K, Messerli SM, Snyder E, Breakefield X, Weissleder R. In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther. 2003;14(13):1247-1254.
11. Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, Yu JS. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res. 2002;62(20):5657-5663.
12. Ehtesham M, Kabos P, GutierrezMA, et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factorrelated apoptosis-inducing ligand. Cancer Res. 2002;62(24):7170-7174.
13. Muller FJ, Snyder EY, Loring JF. Gene therapy: Can neural stem cells deliver? Nat Rev Neurosci. 2006;7(1):75-84.
14. Aboody KS, Bush RA, Garcia E, et al. Development of a tumor-selective approach to treat metastatic cancer. PLoS One. 2006;1:e23.
15. Aboody KS, Najbauer J, Schmidt NO, et al. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol. 2006;8(2):119-126.
16. Benedetti S, Pirola B, Pollo B, et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med. 2000;6(4): 447-450.
17. Aboody KS, Najbauer J, Danks MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther. 2008;15(10):739-752.
18. Ahmed AU, Thaci B, Alexiades NG, et al. Neural Stem Cell-based Cell Carriers Enhance Therapeutic Efficacy of an Oncolytic Adenovirus in an Orthotopic Mouse Model of Human Glioblastoma. Mol Ther. 2011;19(9):1714-1726.
19. Danks MK, Yoon KJ, Bush RA, et al. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res. 2007;67(1):22-25.
20. Frank RT, Najbauer J, Aboody KS. Concise review: stem cells as an emerging platform for antibody therapy of cancer. Stem Cells. 2010;28(11):2084-2087.
21. Yip S, Sabetrasekh R, Sidman RL, Snyder EY. Neural stem cells as novel cancer therapeutic vehicles. Eur J Cancer. 2006;42(9):1298-1308.
22. Aboody K, Capela A, Niazi N, Stern JH, Temple S. Translating stem cell studies to the clinic for CNS repair: Current state of the art and the need for a Rosetta Stone. Neuron. 2011;70(4):597-613.
23. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA. 2004;101(30):10901-10906.
24. Foster PJ, Dunn EA, Karl KE, et al. Cellular magnetic resonance imaging: In vivo imaging of melanoma cells in lymph nodes of mice. Neoplasia. 2008;10(3):207-216.
25. Bulte JW, Zhang S, van Gelderen P, et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA. 1999;96(26):15256- 15261.
26. Bulte JW, Duncan ID, Frank JA. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab. 2002;22(8):899-907.
27. Ozawa T, James CD. Establishing intracranial brain tumor xenografts with subsequent analysis of tumor growth and response to therapy using bioluminescence imaging. J Vis Exp. 2010;(41).
28. Saldanha KJ, Doan RP, Ainslie KM, Desai TA, Majumdar S. Micrometer-sized iron oxide particle labeling of mesenchymal stem cells for magnetic resonance imaging-based monitoring of cartilage tissue engineering. Magn Reson Imaging. 2011;29(1):40-49.
29. Hinds KA, Hill JM, Shapiro EM, et al. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood. 2003;102(3):867-872.
30. Ozawa T, Faddegon BA, Hu LJ, Bollen AW, Lamborn KR, Deen DF. Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures. Int J Radiat Oncol Biol Phys. 2006;66(1):263-270.
31. Ozawa T, Wang J, Hu LJ, Bollen AW, Lamborn KR, Deen DF. Growth of human glioblastomas as xenografts in the brains of athymic rats. In Vivo. 2002;16(1):55-60.
32. Liu W, Frank JA. Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol. 2009;70(2):258-264.
33. Shapiro EM, Skrtic S, Koretsky AP. Sizing it up: Cellular MRI using micron-sized iron oxide particles. Magn ResonMed. 2005;53(2):329-338.
34. Nkansah MK, Thakral D, Shapiro EM. Magnetic poly(lactide-coglycolide) and cellulose particles for MRI-based cell tracking. Magn Reson Med. 2011;65(6):1776-1785.
35. Song HT, Jordan EK, Lewis BK, Gold E, Liu W, Frank JA. Quantitative T2* imaging of metastatic human breast cancer to brain in the nude rat at 3 T. NMR Biomed. 2011;24(3):325-334.
36. Foster-Gareau P, Heyn C, Alejski A, Rutt BK. Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn Reson Med. 2003;49(5):968-971.
37. Schmidt NO, Przylecki W, Yang W, et al. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia. 2005;7(6):623-629.
38. Zhao D, Najbauer J, Garcia E, et al. Neural stem cell tropism to glioma: Critical role of tumor hypoxia. Mol Cancer Res. 2008;6(12):1819-1829.
39. Leenders WP, Kusters B, de Waal RM. Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis Endothelium. 2002;9(2):83-87.
40. Rad AM, Arbab AS, Iskander AS, Jiang Q, Soltanian-Zadeh H. Quantification of superparamagnetic iron oxide (SPIO)-labeled cells using MRI. J Magn Reson Imaging. 2007;26(2):366-374.
41. Zhou R, Idiyatullin D, Moeller S, et al. SWIFT detection of SPIO-labeled stem cells grafted in the myocardium. Magn Reson Med. 2010;63(5): 1154-1161.